Search

The article discusses public health response to the initiation and spread of pandemic COVID-19 in the U.S. from February 24 to April 21, 2020. Topics discussed include continued importation of the virus by travelers infected elsewhere; attendance at professional and social events, resulting in amplification in the host locations and multistate spread; and challenges in virus detection, including limited testing, emergence during the peak months of influenza circulation.

The article discusses a research study on the benefits from immunization during the Vaccines for Children (VFC) program era in the U.S. from 1994 to 2013. Data presented indicate the vaccine coverage rates among pre-school aged children from 1967 to 2012 and the estimated number of illnesses, hospitalizations, and deaths prevented by routine childhood immunization for selected vaccine-preventable diseases among children. The limitations of the research findings are identified.

The article discusses the introduction of vaccines for the prevention of diseases from 1961-2011. It mentions that vaccines were received by children in the U.S. in 1961 for the prevention of various diseases including pertussis, poliomyelitis, and smallpox. It adds that a nationwide immunization program was established from 1961-1988.

Presents guidelines released by U.S. Center for Disease Control to prevent perinatal group B streptococcal (GBS) disease. Procedure for clindamycin and erythromycin risk susceptibility testing of isolates when ordered for penicillin-allergic patients; Recommendation of universal prenatal screening for vaginal and rectal GBS colonization; Adverse effects and unintended consequences of chemoprophylaxis; Vaccines to prevent GBS disease.